We are live on ! Find out more
BBBY

Bed Bath & Beyond Inc

Delisted

BBBY was delisted on the 2nd of May, 2023.

593 hedge funds and large institutions have $11.9B invested in Bed Bath & Beyond Inc in 2014 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 196 increasing their positions, 255 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 814 (+6)

11% more capital invested

Capital invested by funds: $10.7B → $11.9B (+$1.18B)

2% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 64

1% less funds holding

Funds holding: 599593 (-6)

17% less call options, than puts

Call options by funds: $268M | Put options by funds: $324M

23% less repeat investments, than reductions

Existing positions increased: 196 | Existing positions reduced: 255

Holders
593
Holders Change
-6
Holders Change %
-1%
% of All Funds
17.2%
Holding in Top 10
14
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+75%
% of All Funds
0.41%
New
63
Increased
196
Reduced
255
Closed
64
Calls
$268M
Puts
$324M
Net Calls
-$55.7M
Net Calls Change
-$4.19M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
151
Millennium Management
New York
$8.22M -$1.24M -19,748 -14%
BA
152
Bridgewater Associates
Connecticut
$7.97M -$8.43M -134,084 -53%
US Bancorp
153
US Bancorp
Minnesota
$7.92M +$1.65M +26,262 +28%
EA
154
Euclid Advisors
Connecticut
$7.91M +$7.55M +120,150 New
AAMU
155
Amundi Asset Management US
Massachusetts
$7.89M +$7.54M +119,863 New
TSW
156
Thompson Siegel & Walmsley
Virginia
$7.88M +$7.41M +117,814 +6,283%
CEI
157
Clark Estates Inc
New York
$7.83M +$629K +10,000 +9%
KCA
158
KR Capital Advisors
New York
$7.81M -$7.8M -123,984 -51%
MLICM
159
Metropolitan Life Insurance Company (MetLife)
New York
$7.65M -$183K -2,903 -2%
AAM
160
Aberdeen Asset Management
United Kingdom
$7.51M +$1.2M +19,151 +20%
SC
161
Skylands Capital
Wisconsin
$7.39M -$286K -4,550 -4%
Citadel Advisors
162
Citadel Advisors
Florida
$7.18M -$5.71M -90,881 -45%
PFM
163
Parsec Financial Management
North Carolina
$7.15M +$522K +8,295 +8%
Caisse de Depot et Placement du Quebec (CDPQ)
164
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$7.03M -$302K -4,800 -4%
LI
165
Lafayette Investments
Maryland
$6.97M +$204K +3,250 +3%
AIG
166
American International Group
New York
$6.9M +$260K +4,136 +4%
FGA
167
Flood Gamble Associates
New York
$6.58M
TG
168
TCW Group
California
$6.51M -$211K -3,350 -3%
TSBJ
169
Trevor, Stewart, Burton & Jacobsen
New York
$6.39M -$622K -9,900 -9%
ANI
170
American National Insurance
Texas
$6.3M
GH
171
GAM Holding
Switzerland
$6.11M -$2.58M -41,096 -31%
WBC
172
Westpac Banking Corp
Australia
$6.05M +$951K +15,130 +20%
Korea Investment Corp
173
Korea Investment Corp
South Korea
$5.97M -$2.18M -34,700 -28%
WA
174
Westport Advisers
Connecticut
$5.92M
MME
175
Meag Munich Ergo
Germany
$5.79M +$2.12M +33,791 +62%

BBBY Hedge Fund Activity: Q3 2014 in Review

593 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Bed Bath & Beyond Inc (BBBY) for Q3 2014, worth a combined $11.9B — up 11% from $10.7B a quarter earlier.

Sellers outnumbered buyers: 64 funds closed out of BBBY and 63 opened new positions — a net loss of 1 holder — while 255 trimmed existing stakes and 196 added.

The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $243M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $182M.

  • 593 institutional investors held Bed Bath & Beyond Inc (BBBY) as of Q3 2014, down from 599 in Q2 2014.
  • Funds reported $11.9B of Bed Bath & Beyond Inc stock for Q3 2014, up 11% quarter-over-quarter.
  • 63 funds opened new Bed Bath & Beyond Inc positions in Q3 2014 and 64 closed out, a net change of -1 holder.
  • The largest Bed Bath & Beyond Inc buyer in Q3 2014 was Hotchkis & Wiley Capital Management, an estimated $243M added.
  • The largest Bed Bath & Beyond Inc seller in Q3 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $182M sold.

Based on aggregated 13F filings for Q3 2014.